Work

Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

Year: 2009

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Immunology

DOI: 10.1007/s10875-009-9348-y

Authors: Melvin Berger, Paul J. Pinciaro, Arthur Althaus, Mark Ballow, Akhilesh Chouksey, James Moy, Hans Ochs, Mark Stein

Institutions: Case Western Reserve University, Grifols (United States), Women & Children's Hospital of Buffalo, University at Buffalo, State University of New York, Rainbow Babies & Children's Hospital, Rush University Medical Center, University of Washington, Allergy Associates of the Palm Beaches

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2018530537

FWCI: 1.15

Cites: 23

Cited by: 31

Related to: 10